Perimeter Medical Imaging AI, Inc. announced the initiation of an additional clinical trial site at the University of Washington /Fred Hutch Cancer Center located in Seattle, WA. Perimeter is conducting an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined with its proprietary ImgAssist AI software when used during breast conservation surgeries.
Perimeter Medical Imaging AI, Inc.
Equities
PINK
CA71385D1078
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 CAD | -3.64% | -.--% | -56.56% |
May. 14 | Perimeter Medical Imaging AI Reports First Quarter 2024 Financial Results | MT |
May. 14 | Transcript : Perimeter Medical Imaging AI, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.56% | 25.27M | |
-6.72% | 14.46B | |
-47.66% | 2.4B | |
-17.15% | 2.33B | |
-16.69% | 1.38B | |
-.--% | 1.12B | |
+86.67% | 497M | |
+31.24% | 483M | |
+23.36% | 269M | |
-10.21% | 204M |
- Stock Market
- Equities
- PINK Stock
- News Perimeter Medical Imaging AI, Inc.
- Perimeter Medical Imaging AI, Inc. Announces Initiation of Additional Clinical Trial Site at University of Washington / Fred Hutch Cancer Center Located in Seattle, WA